Study finds all Myanmar mouth cancer patients chew betel quid

November 18, 2017

LUGANO, 17 November 2017 - A study in Myanmar has found that all mouth cancer patients use smokeless tobacco, researchers report at the ESMO Asia 2017 Congress. (1) Betel quid chewing often starts in adolescence and is associated with smoking and drinking alcohol, which are also risk factors for oral cancer. (2,3)

According to GLOBOCAN 2012, more than half of oral cancers in the world occur in Asia where an estimated 168,850 new cases were diagnosed in 2012. Of these, approximately 11% of patients were from Southeast Asia. (4)

Lead author Dr Khin Khin Nwe, medical oncologist, Toungoo General Hospital, Toungoo, Myanmar said: "According to previous studies the incidence of oral cancer, also called mouth cancer, in Southeast Asia has been disturbingly high for many years. It has also been shown that smokeless tobacco use is common in this region - for example in Myanmar more than 50% of men use betel quid." (4)

This observational study investigated the lifestyle behaviours of head and neck cancer patients that may have contributed to their disease. The cross-sectional study was conducted in the medical oncology unit of Toungoo General Hospital in 2016. All head and neck squamous cell cancer (HNSCC) patients who came to the hospital were included in the study. Participants were asked about betel quid chewing, smoking, and alcohol.

Of the 307 cancer patients who visited Toungoo Hospital that year, 67 (22%) had HNSCC and were included in the study. Out of the 67 patients, 41 were male and 26 were female. The mean age was 59.2 years (range 36 to 81) for men and 58.7 years (range 19 to 86) for women. The most common cancer site was oral cavity (34.3%), followed by larynx (25.4%), oropharynx (11.9%), nasopharynx (11.9%), hypopharynx (10.4%), lip (4.5%), and nose (1.5%).

Regarding lifestyle habits of the entire study population, 20 patients (30%) chewed betel only; 19 patients (28%) chewed betel and smoked tobacco; 19 patients (28%) chewed betel, smoked tobacco, and consumed alcohol. Two patients smoked tobacco and drank alcohol, two smoked tobacco only, two had none of the risk factors, and information was unavailable for three patients.

All oral cavity (mouth) cancer patients were betel quid chewers. In addition, 48% smoked tobacco and 44% consumed alcohol. The majority (87%) of mouth cancer patients said they kept betel quid in the buccal cavity (cheek) most of the time.

Nwe said: "We found that all patients with mouth cancer chewed betel quid. Most had started the habit as teenagers and had found it too difficult to quit. Betel quid chewing appeared to interact with tobacco smoking and alcohol drinking in an additive way in this population." Nwe concluded: "Chewing of betel quid has been common in Southeast Asia, including Myanmar, for a long time and our study shows that it is a public health problem. Efforts are needed to increase awareness of the risks of betel quid chewing so that adolescents do not start the habit and adults are encouraged to quit. This may help to prevent head and neck cancer."

Commenting on the topic, Dr Makoto Tahara, Chief, Department of Head and Neck Medical Oncology, National Cancer Centre Hospital East, Chiba, Japan, said: "Given the number of health issues associated with chewing betel quid, particularly oral cancer and precancerous conditions such as leukoplakia and oral submucous fibrosis, understanding ways to reduce betel quid chewing is of global public health importance. In the last decade, betel quid has been classified as a group 1 carcinogen by the International Agency for Research on Cancer (IARC)."

"Limited research has been conducted to understand the behavioural and psychosocial factors that lead individuals to initiate and/or maintain betel quid chewing," he continued. "Determining such psychosocial and behavioural risk factors would help design prevention and treatment programmes aiming to reduce the prevalence of betel quid chewing. In many countries within the Western Pacific region, the long-established behaviour of betel quid use is integral to community life, from routine aspects of daily life to ceremonial celebrations. Given the social importance of chewing betel quid, chewers might fear the negative social repercussions associated with quitting. For instance, for an individual attending a social or cultural event where betel quid is offered, refusing it could be construed as an insult by the host." Tahara said: "Interventions designed to treat or prevent betel quid chewing may need to include a strong social/cultural component. For example, such interventions may provide chewers trying to quit with skills regarding how to deal with the social/cultural pressures to chew. With regards to prevention, if social influence is found to play an important role in chewing initiation among youths and young adults, perhaps social influence-based smoking cessation interventions that have been found to be effective in this age group may be adapted to prevent betel quid initiation."
-end-
Notes to Editors

Please make sure to use the official name of the meeting in your reports: ESMO Asia 2017 Congress

References and notes

(1) Abstract 372P_PR 'Head and neck cancer occurrences and Lifestyle habits in Toungoo, Myanmar' will be presented by Khin Khin Nwe during the Poster Display session on Saturday, 18 November 2017, 13:00 to 14:00 (SGT) in the Exhibition area. Annals of Oncology, Volume 28, 2017 Supplement 10.

(2) Betel quid consists of betel leaf, slaked lime and areca nuts, with or without tobacco. Other ingredients may be added according to regional traditions and personal tastes. These include catechu, spices (aniseed, cardamom, nutmeg, cinnamon, cloves), sweeteners (coconut, dried dates, liquorice), and essences (rose essence, menthol, mint, rose petals). The mixture is chewed and may be kept in the mouth for many hours.

(3) IARC Working Group on the Evaluation of Carcinogenic Risk to Humans. Betel-quid and Areca-nut Chewing and Some Areca-nut-derived Nitrosamines. Lyon (FR): International Agency for Research on Cancer; 2004. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 85.)

(4) Cheong SC, et al. Oral cancer in South East Asia: Current status and future directions. Translational Research in Oral Oncology. 2017.

DOI: 10.1177/2057178X17702921

Disclaimer

This press release contains information provided by the authors of the highlighted abstracts and reflects the content of those abstracts. It does not necessarily reflect the views or opinions of ESMO who cannot be held responsible for the accuracy of the data. Commentators quoted in the press release are required to comply with the ESMO Declaration of Interests policy and the ESMO Code of Conduct.

About the European Society for Medical Oncology (ESMO)

ESMO is the leading professional organisation for medical oncology. With 17,000 members representing oncology professionals from 150 countries worldwide, ESMO is the society of reference for oncology education and information. We are committed to supporting our members to develop and advance in a fast-evolving professional environment.

http://www.esmo.org

Twitter: @myESMO; #ESMOAsia17
Facebook: esmo.org
Youtube: ESMOchannel

European Society for Medical Oncology

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.